The multiple sclerosis (MS) drugs as a potential treatment of ARDS in COVID-19 patients

We encourage studies on the effectiveness of multiple sclerosis drugs for the treatment of ARDS in COVID-19 infection. These drugs, through the inhibition of the RhoA/actin-dependent expression of virus receptors in the macrophages and macrophage recruitment to the lungs, have the potential to inhib...

Descripción completa

Detalles Bibliográficos
Autores principales: Kloc, Malgorzata, Ghobrial, Rafik M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392845/
https://www.ncbi.nlm.nih.gov/pubmed/32763844
http://dx.doi.org/10.1016/j.msard.2020.102437

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392845/
https://www.ncbi.nlm.nih.gov/pubmed/32763844
http://dx.doi.org/10.1016/j.msard.2020.102437

Ejemplares similares